PubMed · 2019 · 10 citations · 5 references
MedicineInternal MedicinePharmacotherapyGastrointestinal PharmacotherapySmall Intestine DisordersAngiotensin Ii Receptor BlockersAntihypertensive Drug TherapyAntihypertensive TreatmentSmall Intestine AnatomyVillous Atrophy
Olmesartan, an angiotensin receptor blocker, is a widely spread antihypertensive drug. Seronegative villous atrophy of the small intestine due to olmesartan use was first described in 2012. We present a new case of olmesartan-induced enteropathy and compare it to recent literature. This case might suggest a use of budesonide for treatment.
5
Severe Spruelike Enteropathy Associated With Olmesartan
Alberto Rubio‐Tapia, Margot L. Herman, Jonas F. Ludvigsson et al. · Mayo Clinic Proceedings · 2012 · 494 citations · Full text
Dayanand Kumbla, Sanjay Kumar, Y. V. Kishore Reddy et al. · Indian Heart Journal · 2014 · 10 citations · Full text